Monday, February 23, 2009

Hospira Healthcare Corporation Recalls Two Lots of Desferrioxamine Mesilate for Injection, BP (500 mg and 2g format)

From Health Canada:
Health Canada is advising consumers of a recall of Desferrioxamine Mesilate for Injection (500 mg and 2g format) by Hospira Healthcare Corporation. Certain lots of this product are being recalled because of the potential for very small particles to form after preparation for intravenous administration.

Health Canada is working with the company on the recall of the affected Canadian products from the market. The following specific lots are being recalled:

Lot number: U072231AA in 500mg format
Lot number: U102237AA in 2g format

No comments: